{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:37:04Z","timestamp":1762627024883,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.retram.2025.103520","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T02:21:56Z","timestamp":1747621316000},"page":"103520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anthracycline and arsenic trioxide-based regimens for the treatment of acute promyelocytic leukemia: thiamine levels monitoring importance"],"prefix":"10.1016","volume":"73","author":[{"given":"Reda","family":"Garidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassina","family":"Aftisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djedjiga Si","family":"Tayeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chahrazad","family":"Benchouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Sari Hassoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assia","family":"Alem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamim","family":"Alsuliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.retram.2025.103520_bib0001","doi-asserted-by":"crossref","first-page":"33\u201165","DOI":"10.1007\/s40487-018-0091-5","article-title":"Acute promyelocytic leukemia: a history over 60 years\u2014from the most malignant to the most curable form of Acute leukemia","volume":"7","author":"Thomas","year":"2019","journal-title":"Oncol Ther"},{"issue":"3","key":"10.1016\/j.retram.2025.103520_bib0002","first-page":"44\u201154","article-title":"A review of arsenic trioxide and acute promyelocytic leukemia","volume":"8","author":"Alimoghaddam","year":"2014","journal-title":"Int J Hematol-Oncol Stem Cell Res"},{"issue":"1","key":"10.1016\/j.retram.2025.103520_bib0003","article-title":"Severe acute axonal neuropathy following treatment with arsenic trioxide for acute promyelocytic leukemia: a case report","volume":"8","author":"K\u00fchn","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"9","key":"10.1016\/j.retram.2025.103520_bib0004","doi-asserted-by":"crossref","first-page":"3481\u20112","DOI":"10.1182\/blood-2001-12-0325","article-title":"Severe neurotoxicity following arsenic therapy for acute promyelocytic leukemia: potentiation by thiamine deficiency","volume":"99","author":"Yip","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2025.103520_bib0005","doi-asserted-by":"crossref","first-page":"221\u20119","DOI":"10.1177\/1074248414552901","article-title":"Examination of the effects of thiamine and thiamine pyrophosphate on Doxorubicin-induced experimental cardiotoxicity","volume":"20","author":"Polat","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:34:02Z","timestamp":1762626842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318625000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2452318625000297"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2025.103520","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anthracycline and arsenic trioxide-based regimens for the treatment of acute promyelocytic leukemia: thiamine levels monitoring importance","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2025.103520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103520"}}